KR20070111532A - 상피 및 다른 세포 및 조직 재생용 조성물 및 방법 - Google Patents

상피 및 다른 세포 및 조직 재생용 조성물 및 방법 Download PDF

Info

Publication number
KR20070111532A
KR20070111532A KR1020077021369A KR20077021369A KR20070111532A KR 20070111532 A KR20070111532 A KR 20070111532A KR 1020077021369 A KR1020077021369 A KR 1020077021369A KR 20077021369 A KR20077021369 A KR 20077021369A KR 20070111532 A KR20070111532 A KR 20070111532A
Authority
KR
South Korea
Prior art keywords
blood
cell
tvemf
stem cells
blood stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020077021369A
Other languages
English (en)
Korean (ko)
Inventor
도니 러드
Original Assignee
리제네텍 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리제네텍 인코포레이티드 filed Critical 리제네텍 인코포레이티드
Publication of KR20070111532A publication Critical patent/KR20070111532A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2529/00—Culture process characterised by the use of electromagnetic stimulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020077021369A 2005-02-28 2006-02-27 상피 및 다른 세포 및 조직 재생용 조성물 및 방법 Withdrawn KR20070111532A (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US65728805P 2005-02-28 2005-02-28
US65728305P 2005-02-28 2005-02-28
US65754505P 2005-02-28 2005-02-28
US60/657,283 2005-02-28
US60/657,288 2005-02-28
US60/657,545 2005-02-28

Publications (1)

Publication Number Publication Date
KR20070111532A true KR20070111532A (ko) 2007-11-21

Family

ID=36941695

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077021369A Withdrawn KR20070111532A (ko) 2005-02-28 2006-02-27 상피 및 다른 세포 및 조직 재생용 조성물 및 방법

Country Status (9)

Country Link
US (2) US20060193837A1 (enExample)
EP (1) EP1853282A4 (enExample)
JP (1) JP2008531698A (enExample)
KR (1) KR20070111532A (enExample)
BR (1) BRPI0608294A2 (enExample)
CA (1) CA2601306A1 (enExample)
EA (1) EA200701598A1 (enExample)
IL (1) IL185556A0 (enExample)
WO (1) WO2006093881A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060193839A1 (en) * 2005-02-28 2006-08-31 Donnie Rudd Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
US20090081752A1 (en) * 2007-09-24 2009-03-26 Dennis Robert G Bioreactor, kit and method of using same
US8993231B2 (en) * 2008-03-18 2015-03-31 Marshall University Research Corporation Methods for stem cell production and therapy
JP6691048B2 (ja) 2013-10-24 2020-04-28 オスペダーレ サン ラファエレ エス．アール．エル 方法
US9410143B1 (en) 2014-06-10 2016-08-09 Endonovo Therapeutics, Inc. Biological molecules produced by electromagnetically stimulating living mammalian cells

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6497875B1 (en) * 1996-04-26 2002-12-24 Case Western Reserve University Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US6485963B1 (en) * 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
AU2002220712A1 (en) * 2000-11-29 2002-06-11 William Rader Stem cells, method for expansion in vitro and use thereof
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US20040076620A1 (en) * 2002-09-03 2004-04-22 Donnie Rudd Method of repairing primate mammalian tissue
JPWO2004045666A1 (ja) * 2002-11-15 2006-03-16 株式会社産学連携機構九州 臓器の再生方法
AU2004212009B2 (en) * 2003-02-13 2010-07-29 Celularity Inc. Use of umbilical cord blood to treat individuals having a disease, disorder or condition
US20060205071A1 (en) * 2003-07-17 2006-09-14 Gamida-Cell Ltd. Methods for ex-vivo expanding stem/progenitor cells
US20050084962A1 (en) * 2003-08-20 2005-04-21 Bruce Simon Methods of treatment using electromagnetic field stimulated stem cells
US20080057042A1 (en) * 2005-01-27 2008-03-06 Donnie Rudd Method of providing readily available cellular material derived from cord blood, and a composition thereof
US20080050348A1 (en) * 2006-02-27 2008-02-28 Donnie Rudd Method and composition for repairing heart tissue
US20080075700A1 (en) * 2006-02-27 2008-03-27 Wolf David A Method and composition for treating diabetes

Also Published As

Publication number Publication date
EP1853282A2 (en) 2007-11-14
CA2601306A1 (en) 2006-09-08
US20080171020A1 (en) 2008-07-17
WO2006093881A3 (en) 2007-11-29
JP2008531698A (ja) 2008-08-14
BRPI0608294A2 (pt) 2010-01-12
WO2006093881A2 (en) 2006-09-08
IL185556A0 (en) 2008-01-20
EA200701598A1 (ru) 2008-02-28
US20060193837A1 (en) 2006-08-31
EP1853282A4 (en) 2010-04-28

Similar Documents

Publication Publication Date Title
US20070117087A1 (en) Method of providing readily available cellular material derived from peripheral blood, and a compositoin thereof
KR20070103431A (ko) 제대혈로부터 유래한 용이하게 가능한 세포 물질을제공하는 방법 및 그의 조성물
US20080075700A1 (en) Method and composition for treating diabetes
US20080171020A1 (en) Method and composition for repairing epithelial and other cells and tissue
KR20070112205A (ko) 심장 조직 재생용 조성물 및 방법
US20080075704A1 (en) Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
KR20070111533A (ko) 당뇨병 치료용 조성물 및 방법
WO2009025827A1 (en) Method and composition for repairing epithelial and other cells and tissue
CN101166820A (zh) 用于修复上皮和其它细胞及组织的方法和组合物
CN101160046A (zh) 提供容易获得的源于外周血的细胞材料的方法及其组合物
CA2597971A1 (en) Method and composition for repairing epithelial and other cells and tissue
MX2007010452A (es) Metodo y composiciones para reparar celulas y tejido epitelial y otros
CA2595744A1 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
CA2597972A1 (en) Method and composition for treating diabetes

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070917

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid